BIOMAT Database Logo BIOMAT Database Logo

Failure to correct nitrous oxide toxicity with folinic acid. 1982

P O Skacel, and I Chanarin, and A Hewlett, and J F Nunn

UI MeSH Term Description Entries
D008534 Megaloblasts Red blood cell precursors, corresponding to ERYTHROBLASTS, that are larger than normal, usually resulting from a FOLIC ACID DEFICIENCY or VITAMIN B 12 DEFICIENCY. Megaloblast
D009609 Nitrous Oxide Nitrogen oxide (N2O). A colorless, odorless gas that is used as an anesthetic and analgesic. High concentrations cause a narcotic effect and may replace oxygen, causing death by asphyxia. It is also used as a food aerosol in the preparation of whipping cream. Laughing Gas,Nitrogen Protoxide,Gas, Laughing,Oxide, Nitrous
D001855 Bone Marrow Diseases Diseases involving the BONE MARROW. Bone Marrow Disease,Disease, Bone Marrow,Diseases, Bone Marrow,Marrow Disease, Bone,Marrow Diseases, Bone
D002955 Leucovorin The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS. Calcium Leucovorin,Citrovorum Factor,Folinic Acid,N(5)-Formyltetrahydrofolate,5-Formyltetrahydrofolate,5-Formyltetrahydropteroylglutamate,Calcium Folinate,Folinic Acid-SF,Leucovorin, (D)-Isomer,Leucovorin, (DL)-Isomer,Leucovorin, (R)-Isomer,Leucovorin, Calcium (1:1) Salt,Leucovorin, Calcium (1:1) Salt, (DL)-Isomer,Leucovorin, Calcium (1:1) Salt, Pentahydrate,Leucovorin, Monosodium Salt,Leukovorin,Leukovorum,Wellcovorin,5 Formyltetrahydrofolate,5 Formyltetrahydropteroylglutamate,Acid, Folinic,Factor, Citrovorum,Folinate, Calcium,Folinic Acid SF,Leucovorin, Calcium,Monosodium Salt Leucovorin
D003857 Deoxyuridine 2'-Deoxyuridine. An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemias due to vitamin B12 and folate deficiencies. (beta 1-(2-Deoxyribopyranosyl))thymidine
D004913 Erythrocytes, Abnormal Oxygen-carrying RED BLOOD CELLS in mammalian blood that are abnormal in structure or function. Abnormal Erythrocytes,Abnormal Erythrocyte,Erythrocyte, Abnormal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P O Skacel, and I Chanarin, and A Hewlett, and J F Nunn
Folinic acid prevents megaloblastic changes associated with nitrous oxide.
October 1988, Anesthesia and analgesia,
P O Skacel, and I Chanarin, and A Hewlett, and J F Nunn
Folinic acid protection against nitrous oxide teratogenicity in the rat.
May 1986, British journal of anaesthesia,
P O Skacel, and I Chanarin, and A Hewlett, and J F Nunn
Megaloblastic bone marrow changes after repeated nitrous oxide anaesthesia. Reversal with folinic acid.
December 1986, British journal of anaesthesia,
P O Skacel, and I Chanarin, and A Hewlett, and J F Nunn
Folinic acid protection against hematopoietic depression induced by nitrous oxide in rats.
August 1993, Anesthesia and analgesia,
P O Skacel, and I Chanarin, and A Hewlett, and J F Nunn
Halothane prevents nitrous oxide teratogenicity in Sprague-Dawley rats; folinic acid does not.
August 1988, Teratology,
P O Skacel, and I Chanarin, and A Hewlett, and J F Nunn
Prevention of nitrous oxide-induced megaloblastic changes in bone marrow using folinic acid.
February 1984, British journal of anaesthesia,
P O Skacel, and I Chanarin, and A Hewlett, and J F Nunn
Nitrous Oxide Toxicity With Subsequent Recovery.
October 2023, Neurology,
P O Skacel, and I Chanarin, and A Hewlett, and J F Nunn
Toxicity of nitrous oxide.
March 2003, Best practice & research. Clinical anaesthesiology,
P O Skacel, and I Chanarin, and A Hewlett, and J F Nunn
Toxicity of nitrous oxide.
February 1971, Annals of the Royal College of Surgeons of England,
P O Skacel, and I Chanarin, and A Hewlett, and J F Nunn
[Toxicity of nitrous oxide].
October 2001, Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS,
Copied contents to your clipboard!